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Objective: Italian Road Law limits driving while undergoing treatment with certain kinds of 
medication. Here, we report the results of a test, run as a smartphone application (app), assess-
ing auditory and visual reflexes in a sample of 300 drivers. The scope of the test is to provide 
both the police force and medication-taking drivers with a tool that can evaluate the individual’s 
capacity to drive safely.
Methods: The test is run as an app for Apple iOS and Android mobile operating systems 
and facilitates four different reaction times to be assessed: simple visual and auditory reaction 
times and complex visual and auditory reaction times. Reference deciles were created for the 
test results obtained from a sample of 300 Italian subjects. Results lying within the first three 
deciles were considered as incompatible with safe driving capabilities.
Results: Performance is both age-related (r0.5) and sex-related (female reaction times were 
significantly slower than those recorded for male subjects, P0.05). Only 21% of the subjects 
were able to perform all four tests correctly.
Conclusion: We developed and fine-tuned a test called Safedrive that measures visual and 
auditory reaction times through a smartphone mobile device; the scope of the test is two-fold: 
to provide a clinical tool for the assessment of the driving capacity of individuals taking pain 
relief medication; to promote the sense of social responsibility in drivers who are on medication 
and provide these individuals with a means of testing their own capacity to drive safely.
Keywords: visual reaction time, auditory reaction time, opioids, Safedrive
Introduction
Possessing a driving license plays a fundamental role in everyday life as it provides 
individuals with the liberty to have a mobile lifestyle. The right to such a lifestyle is 
also decided taking into account people affected by pathologies that require pharma-
cological treatment. Italian Road Law (article 187) stipulates restrictions regarding 
driving whilst under the influence of certain kinds of drugs, and these drugs are listed 
in a specific table published, and continuously updated, by the Ministry of Health. In 
addition to all illegal substances, this list includes the majority of benzodiazepines and 
opioid analgesics. The driving license is withdrawn from a driver when one or more 
of the listed substances are found in the individual’s biological fluids and a physician 
or the police force concomitantly determine his/her psychophysical status as being 
altered – currently determined via the compilation of a report, the format of which is 
qualitative only and non-standardized.
Pharmacological therapies may alter the psychophysical status of drivers, with 
possible negative effects upon driving;1 thus, driving under the influence of such 
therapies could represent a potential cause of road accidents, with grave consequences 
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in human, financial, and socio-economic terms. The fol-
lowing question therefore arises: should patients who drive 
whilst adhering to their pharmacological prescriptions 
be categorized as dangerous drivers due to their use of a 
determined drug type, or are we dealing with uninformed 
prejudice?
The authors are interested in this issue due to the wide-
spread use of many of the drugs listed by the Ministry 
of Health as being prohibited when driving (particularly 
opioids); moreover, in addition to the potential increased 
probability of the patient suffering a road accident whilst 
on certain types of pain therapy, pain itself, if left untreated, 
could result in the deterioration of driving performance.2 
To address this problem and in order to offer an objective 
tool to both medication-taking drivers and the police force 
for the evaluation of safe driving reflexes, namely, auditory 
and visual reflexes, we have developed a test that is executed 
using a dedicated smartphone app. The final purpose is to 
increase road safety for the patients taking psychotropic drugs 
by using a tool simply and “road side.” We have chosen the 
visual and auditory reflexes because they are already used 
in our country (Italy) for the renewal of some types of driv-
ing licenses.
Materials and methods
In collaboration with software house Mobile 3D S.r.l. (Udine, 
Italy), we have developed an app for iPhones using an iOS 
Apple language3 that allows the user to perform the following 
four different tests of visual and auditory reaction times:
1. Simple visual test: The subject has to press a specific 
point on the smartphone’s screen and then remove his/
her finger when the circle in the center of the screen 
lights up in green. The software measures the time taken 
to complete this operation and evaluates eventual errors 
in its execution (for instance, if the screen was not well 
pressed in the beginning or if the finger was removed too 
early or too late by more than 2 seconds). If the subject 
commits one or two errors, he/she must redo the test 
until ten repetitions have been successfully executed; if 
three errors are committed, the test will be interrupted 
and considered failed. The time between the screen being 
touched and the green light showing will randomly vary 
between 0.5 seconds and 2 seconds.
2. Simple auditory test: The subject has to press a precise 
point on the screen and remove his/her finger when the 
auditory tone, resembling a car horn, is heard. The soft-
ware measures the time taken to complete this operation 
and evaluates eventual errors in its execution.
3. Complex auditory test: The subject has to press a bar on 
the screen and move his/her finger left or right toward the 
image of a dog or a cat according to whether dog or cat 
sound (bark or meow) is heard. The software measures 
the time taken to complete this operation and evaluates 
eventual errors in its execution.
4. Complex visual test: The subject has to press a bar on 
the screen and move his/her finger left or right toward 
the color green or red, in accordance with the color that 
appears in a circle in the center of the screen. The software 
measures the time taken to complete this operation and 
evaluates eventual errors in its execution.
When all four tests have been completed, the software 
presents a summary of the test results, indicating the total 
number of errors made as well as the mean time in milli-
seconds necessary to complete each test and the variance (a 
measure of the repeatability of the subject’s performance). 
The results obtained can also be exported using the device’s 
e-mail software; this option will enable the police to central-
ize the data collected in real time, so that the data can be 
used in parallel with the analysis of any biological samples 
obtained.
After approval by the Regional Ethical Committee of 
Udine and considering the actual demographic distribution of 
the Italian adult population (as reported by the National Insti-
tute of Statistics), subdivided by sex and age and normalized 
for adults over the age of 18 years (the legal minimum age 
for sitting a driving test in Italy), a sample of 300 individu-
als was selected to undergo the test, and their ages and sex 
corresponded with the above-mentioned distribution.
Inclusion criteria: Adult subjects (age 18 years) fall-
ing into the age and sex subgroups in accordance with the 
demographic distribution of Italian adults as reported by 
the Italian 2001 census; subjects able to drive, after written 
informed consent collection.
Exclusion criteria: Linguistic barriers; cognitive altera-
tions incompatible with performing the tests; skeletal, mus-
cular, or neurological disorders incompatible with performing 
the tests; the use of drugs acting upon the central or peripheral 
nervous system; eye diseases (excluding corrected refractive 
errors); and ear diseases (deafness or partial hearing loss).
statistical analysis
All test results obtained using the app were e-mailed to a mail 
box created ad hoc. The data were imported and analyzed 
using Excel 2007 software (Microsoft, Seattle, WA, US).
The mean and variance values for all completed tests 
were used to create the corresponding deciles. A test was 
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considered as having been “passed” if: the total number of 
errors committed in each subtest was two or less. The subjects 
passed all four subtests successfully, and the corresponding 
mean reaction time (expressed in milliseconds) and variance 
(expressed in milliseconds) lay between the fourth and tenth 
deciles.
The requirement for a driver’s performance values to fall 
above the third decile for both reaction time and variance was 
selected in accordance with item 119 of Italian Road Law, 
where a complete description of necessary requisites for 
obtaining and maintaining various types of driving licenses, 
including nautical driving licenses, is described.
Results
Once the reference deciles for the Italian population were 
obtained (Table 1) and the number of subjects who had 
passed the entire test were calculated, the subjects were then 
categorized according to the age and the sex (Table 2) and 
the results obtained by the app were analyzed according to 
these age and sex categories by decade (the subjects aged 
between 20 years and 90 years were considered; the divi-
sion of age by decade was used as previously described by 
Cox4). Pearson’s regression coefficient, r, was calculated 
using Microsoft Excel software (Table 3) to evaluate how 
performance varies in relation to the age. Student’s two-
tailed t-tests for unpaired samples were calculated to analyze 
potential correlations with sex (Table 4).
A female to male predominance (51.7% versus 48.3%) 
was observed, with females exhibiting a higher mean age 
compared to males (53.4 years versus 49.9 years, P0.05, 
not significant, NS; Student’s t-test for unpaired samples).
Table 1 presents the reference deciles for the sample 
population (stratified by age decade, starting with the age of 
20 and ending with the age of 90) for each of the four subtests 
conducted (the mean reaction time in ms and the variance 
were analyzed separately); this table was used to fine-tune 
the app itself by inserting the deciles values.
Table 2 and Figure 1 describe and quantify the subjects that 
successfully passed all four subtests in relation to both compo-
nents, ie, reaction time and variance (to pass the test, the mean 
reaction time and variance must lie between the fourth and 
tenth deciles). It is important to highlight here that only 21% 
of the subjects successfully completed the entire test (25.51% 
of males versus 16.77% of females); when further stratified by 
the age decade, the highest percentage of subjects successfully 
completing the entire test were aged between 20–29 years and 
30–39 years, with success rates diminishing for the successive 
age groups. For the age groups over 60 years, all the subjects 
successfully completing the test were male.
Table 3 analyzes the correlation between age and perfor-
mance (expressed as Pearson’s linear regression coefficient, r); 
statistical significance (r0.5) was noted for all tests inde-
pendent of whether the analysis considered all subjects 
together or each sex separately.
Table 1 reference deciles for mean reaction times (ms) and variance (ms)
Test 1 mean Test 1 variance Test 2 mean Test 2 variance
10th decile 279.93 0.1415 315 0.1493
9th decile 294.3–279.93 0.1858–0.1415 334.33–315 0.166–0.1493
8th decile 308–294.3 0.2192–0.1858 346.38–334.33 0.1867–0.166
7th decile 324.35–308 0.2413–0.2192 366.61–346.38 0.2061–0.1867
6th decile 351.99–324.35 0.2672–0.2413 380.55–366.61 0.2202–0.2061
5th decile 380.06–351.99 0.2902–0.2672 402.18–380.55 0.2417–0.2202
4th decile 439.82–380.06 0.3169–0.2902 444.28–402.18 0.2665–0.2417
3rd decile 529.92–439.82 0.3859–0.3169 561.05–444.28 0.2854–0.2665
2nd decile 671.31–529.92 0.4618–0.3859 815.18–561.05 0.3407–0.2854
1st decile 671.31 0.4618 815.18 0.3407
Test 3 mean Test 3 variance Test 4 mean Test 4 variance
10th decile 438 0.1064 535.37 0.1291
9th decile 473.66–438 0.1222–0.1064 560.99–535.37 0.1470–0.1291
8th decile 503.02–473.66 0.1370–0.1222 574.5–560.99 0.1633–0.1470
7th decile 526.28–503.02 0.1499–0.1370 605.57–574.5 0.1789–0.1633
6th decile 547.45–526.28 0.1641–0.1499 639.5–605.57 0.1919–0.1789
5th decile 587.82–547.45 0.1755–0.1641 673.75–639.5 0.2041–0.1919
4th decile 635.69–587.82 0.1927–0.1755 728.89–673.75 0.2208–0.2041
3rd decile 707.32–635.69 0.2216–0.1927 821–728.89 0.2379–0.2208
2nd decile 936.97–707.32 0.2606–0.2216 1067.48–821 0.2667–0.2379
1st decile 936.97 0.2606 1067.48 0.2667
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No significant differences were found when we analyzed 
for correlations between age and variance, irrespective of 
whether subjects were analyzed altogether or subdivided by 
sex (results not indicated in the table).
Finally, we analyzed for differences between the two 
sexes (Table 4) with regard to performance in each of 
the four subtests: Student’s two-tailed t-tests for unpaired 
samples revealed a statistical significance (P0.05) in favor 
of the males for each of the four subtests analyzed; when we 
stratified the analysis according to the age decade, statistical 
significances were revealed between sexes for the age groups 
of 30–39 and 50–59.
Discussion
The decision to assess visual and auditory reflexes as a way of 
evaluating the psychophysical state of drivers was not casual: in 
the literature, driving performance has been evaluated in differ-
ent ways: through the use of driving simulators,5 “on the road” 
tests conducted on roads closed to traffic,6 using the Vienna test 
(used in some European countries to evaluate driving suitability 
for driving license renewals or when a driving license is to be 
obtained for the first time7), or through the assessment of visual 
and/or auditory reflexes.8 We chose to evaluate visual and audi-
tory reflexes as a proxy of driving “fitness,” not only because 
they are easy to assess using software for mobile devices, but 
principally because threshold values regarding these reflexes 
are already indicated in Italian Road Law.
The time employed to move the finger away from the 
screen was assessed rather than the other way round in order 
to eliminate the bias that would be created by initial finger 
distance from the screen, as it would be very difficult to stan-
dardize this distance. We also developed a software graphical 
interface so that left-handed individuals could perform the 
test in the same way as right-handed individuals.
As simple reflexes, we used the switching on of a light 
(test 1, simple visual) and an auditory tone (test 2, simple 
auditory), while as complex reflexes we introduced color 
discrimination (test 3, complex visual) and sound type 
discrimination tests (test 4, complex auditory) that require 
advanced processing by the brain. The speed of test execu-
tion was measured in milliseconds and its repetitiveness by 
means of the variance.
The fact that only 21% of subjects passed the entire test 
allows us to make the following considerations: considering 
that visual and auditory reflex tests are only obligatory in Italy 
for special types of driving licenses and not for motorcycle 
licenses (Type A driving license) or for vehicles that weigh 
less than 3,500 kg (Type B driving license), we believe that 
Italian Road Law provisions regarding reflex reaction times 
are too rigorous and would prevent a large portion of capable 
drivers from obtaining special types of driving licenses.
The anticipated negative correlation between subject 
age and performance has been previously reported in the 
literature9,10 and correlates with a series of cerebral deterio-
rations involved in aging; the superior performance of male 
drivers over females has also been previously observed.11,12 
However, the present results indicate that even though male 
performances are statistically superior to those of females, 
there are two age decades that predominantly contribute 
toward this overall result: subjects aged 30–39 years and 
50–59 years. At present, we can offer no explanation for 
this phenomenon; a larger sample may better clarify this 
result.
Table 2 subjects successfully passing all four tests
Age  
(years)
Males  
(n)
Females  
(n)
Males  
enrolled (n)
Females  
enrolled (n)
20–29 8 (44.44%) 6 (37.5%) 18 16
30–39 9 (34.61%) 8 (33.33%) 26 24
40–49 9 (30%) 8 (27.59%) 30 29
50–59 5 (20.83%) 4 (16.66%) 24 24
60–69 5 (21.74%) 0 23 26
70–79 1 (6.25%) 0 16 21
80–89 0 0 8 12
90 0 0 1 2
Total 37 (25.51%) 26 (16.77%) 146 154
Table 3 Pearson’s regression coefficient, r, between age (all sub­
jects, men only, and women only) and test performance
Pearson’s r Test 1 Test 3 Test 2 Test 4
age total 0.6* 0.698* 0.566* 0.648*
age males 0.599* 0.638* 0.570* 0.575*
age females 0.609* 0.736* 0.556* 0.697*
Note: *if Pearson’s r0.5.
Table 4 student’s two­tailed t­tests for unpaired samples to 
assess for performance differences between the two sexes
Student’s t-test Test 1 Test 2 Test 3 Test 4
20–29 years 979 0.94 747 362
30–39 years 0.021* 0.018* 0.004* 0.044*
40–49 years 147 283 758 516
50–59 years 0.041* 0.026* 88 0.030*
60–69 years 914 327 713 823
70–79 years 0.049* 0.13 85 804
80–89 years 161 92 67 955
90 years na na na na
Total 0.0011* 0.0145* 0.0077* 0.0128*
Note: *P0.05, student’s t­test.
Abbreviation: na, not available.
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The authors13 recently studied with the “Safedrive” app a 
group of patients before and after opioid therapy (oxycodon–
naloxon association); the results showed that pain aggravates 
the visual and auditory reflexes status when patients with severe 
non-cancer pain (numerical rate scale [NRS] 6 on a scale with 
eleven points) are compared with healthy volunteers. After two 
weeks of opioid therapy (and pain control with NRS 3), the 
authors showed that the opioid therapy did not adversely affect 
the patients’ performance, and were found to be better than 
those of healthy volunteers with a blood alcohol concentration 
less than 0.5 g/L, which is allowed by Italian Road Law.
This software could be useful in a number of ways; for 
example, a significant proportion of the general population 
is currently undergoing treatment with drugs (including, 
opioid analgesics, benzodiazepines, etc.,) that act on the 
central nervous system. Thus, the present app represents a 
simple-to-use and free mobile tool for the evaluation of psy-
chophysical status (in a similar sense to home breathalyzers), 
the responsible use of which could reduce the probability of 
the subject being involved in a road accident and subsequent 
prosecution by the authorities for driving under the influence 
of psychotropic substances. The police force would also 
benefit from being equipped with this app, as they would 
have an objective and repeatable procedure for evaluating 
psychophysical status without the need for the services of a 
physician. The actual situation in Italy regarding the evalu-
ation of these parameters is highly variable as no objective 
and repeatable method has been available.
As our end objective is to offer this tool to the police 
force, the software was developed and fine-tuned considering 
the specific driver skills required by Italian Road Law.
The overall goal of this research is to generate respon-
sible driving culture, provide information, and promote the 
awareness of the problem of driving under medication so that 
patients taking psychotropic drugs (in the range of millions 
of patients per year in Italy alone) avoid driving when expe-
riencing an altered psychophysical status. On the other hand, 
it is also fair that patients taking medication should be able 
to enjoy an autonomous lifestyle when they are fit to do so; 
indeed, psychotropic drugs (opioid analgesics in particular) 
do not necessarily create problems for driving, whereas other 
drugs like antihistamines and benzodiazepines are not always 
safe (data available on www.druid-project.eu); thus, patients 
who use opioid analgesics or other psychotropic drugs are 
often being unfairly discriminated against.
This app can contribute to supporting and helping both 
patients and traffic police (especially if the app’s use becomes 
widespread on the national level) so that in addition to 
subjective evaluations, a realistic objective parameter that 
measures visual and auditory reflexes can help promote and 
ensure good driving performance despite the prejudices and 
concerns regarding the use of psychotropic and narcotic drugs 
listed by the Ministry of Health during driving.
Conclusion
We have designed, developed, and fine-tuned the software 
for a test to assess visual and auditory reaction times. The 
scope of the test is two-fold: to provide a clinical tool for the 
assessment of driving capacity of drivers who are on pain 
relief medication (helping to avoid the unfair prosecution of 
drivers, according to article 187 of Italian Road Law) and; 
to promote the sense of social responsibility in drivers on 
Figure 1 Quantification of subjects who successfully passed all four subtests.
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medication and provide these individuals with a means of 
testing their own capacity to drive safely, thereby reducing 
the number of road accidents caused by inadequate visual 
and auditory reaction times.
This software holds the potential to bridge the statistical–
epidemiological gap during the evaluation of the role of the 
psychophysical status of a driver involved in a car accident. 
In 2011, no data regarding car crashes caused by alterations 
in driver psychophysical status were listed or analyzed in 
the National Institute of Statistics Annual Report directly 
due to the absence of an objective and repeatable method of 
psychophysical performance evaluation.
All these considerations should contribute toward 
reducing patient ignorance about the risks associated with 
driving whilst taking certain forms of medication as well as 
unnecessary apprehension and anxiety surrounding the use 
of some psychotropic drugs – in particular, analgesic opioids, 
which, when administrated correctly, may not necessarily 
present problems in patients that need to drive, especially if 
slow-release preparations are used (for example, oxycodone-
controlled release14).
On the other hand, weak opioids that are not listed in the 
ministerial table have sometimes been found in the blood of 
car accident victims.15
A simple, objective, “road side” tool with the function 
of measuring the driving abilities appears to be very impor-
tant in order to ensure road safety of all citizens and avoid 
discrimination of patients with chronic pain.
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